Search company, investor...

Fosun Long March

About Fosun Long March

Fosun Long March is a municipal high-tech enterprise integrating product development, production, and sales of in vitro diagnostics, laboratory reagents, and diagnostic equipment. It is based in Baoshan, Shanghai.

Headquarters Location

830 Chengyin Road

Baoshan, Yunnan, 201900,


Missing: Fosun Long March's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Fosun Long March's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Fosun Long March

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fosun Long March is included in 1 Expert Collection, including Health Monitoring & Diagnostics.


Health Monitoring & Diagnostics

206 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

Latest Fosun Long March News

COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Landscape Report 2021 -

Feb 10, 2022

COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Landscape Report 2021 - The report provides comprehensive information about the COVID 19 Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. NAAT involves amplification of specific nucleic acid sequences of SARS-CoV-2 virus by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to antigen identification methods. Multiple targets are used in PCR to detect the different types of SARS-Cov-2. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope Extensive coverage of the COVID 19 Nucleic Acid Amplification Tests (NAATs) under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of COVID 19 Nucleic Acid Amplification Tests (NAATs) and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage The report provides key clinical trial data of ongoing trials specific to pipeline products Recent developments in the segment / industry Reasons to Buy Formulate significant competitor information, analysis, and insights to improve R&D strategies Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage Identify and understand important and diverse types of COVID 19 Nucleic Acid Amplification Tests (NAATs) under development Develop market-entry and market expansion strategies Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline In-depth analysis of the product's current stage of development, territory and estimated launch date Key Topics Covered: 3 Products under Development 3.2 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Territory 3.3 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Regulatory Path 3.4 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Estimated Approval Date 3.5 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Ongoing Clinical Trials 4 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Pipeline Products under Development by Companies 4.1 COVID 19 Nucleic Acid Amplification Tests (NAATs) Companies - Pipeline Products by Stage of Development 4.2 COVID 19 Nucleic Acid Amplification Tests (NAATs) - Pipeline Products by Stage of Development 5 COVID 19 Nucleic Acid Amplification Tests (NAATs) Companies and Product Overview 6 COVID 19 Nucleic Acid Amplification Tests (NAATs)- Recent Developments 6.1 Nov 15, 2021: Applied DNA subsidiary LineaRx receives repeat orders for LinearDNA, adds federally funded cancer research laboratory as CRO customer 6.2 Nov 09, 2021: Research publication demonstrates utility of Applied DNA's LinearDNA in non-viral CAR T manufacturing systems 6.3 May 19, 2021: FDA grants EUA to Roche's Covid-19 test for asymptomatic people 7 Appendix Advanced MedTech Holdings Pte Ltd Aegea Biotechnologies Inc Beijing Ditan Hospital bioMerieux SA Co-Diagnostics Inc Guangzhou Deaou Biotechnology Co Ltd Guangzhou Weiyuan Gene Technology Co Ltd Hangzhou Bigfish Bio-tech Co Ltd Hangzhou Dan Wei Biotechnology Co Ltd Healgen Scientific LLC Inflammatix Inc LabGenomics Co Ltd Long Island Biotech Inc NDFOS Co Ltd Norgen Biotek Corp RTA Laboratories Sacace Biotechnologies Srl Shanghai Fosun Long March Medical Science Co Ltd Shenzhen Second People's Hospital Vazyme Biotech Co Ltd Vivera Pharmaceuticals Inc West Virginia University School of Medicine Wuhan EasyDiagnosis Biomedicine Co Ltd Yaathum Biotech Pvt Ltd Contacts For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Editor Details is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2022.1.24.1 You are leaving Disclaimer: You are now leaving website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the website and will be redirected to another site. These sites are not under the control of is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

Fosun Long March Frequently Asked Questions (FAQ)

  • Where is Fosun Long March's headquarters?

    Fosun Long March's headquarters is located at 830 Chengyin Road, Baoshan.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.